{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:59:32Z","timestamp":1761541172781},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/ico.0b013e3182a48009","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T09:04:33Z","timestamp":1379667873000},"page":"1488-1492","source":"Crossref","is-referenced-by-count":11,"title":["Subconjunctival Injection of Low-Molecular-Weight Heparin\u2013Taurocholate 7 Inhibits Corneal Neovascularization"],"prefix":"10.1097","volume":"32","author":[{"given":"Sam Young","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myoung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hungwon","family":"Tchah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":". Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-16-20210204","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00003226-200307000-00018","article-title":". Photodynamic therapy of corneal neovascularization with verteporfin.","volume":"22","author":"Fossarello","year":"2003","journal-title":"Cornea"},{"key":"R3-16-20210204","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/exer.1998.0527","article-title":". Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization.","volume":"67","author":"Gohto","year":"1998","journal-title":"Exp Eye Res"},{"key":"R4-16-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1167\/iovs.01-1277","article-title":". VEGF-dependent conjunctivalization of the corneal surface.","volume":"44","author":"Joussen","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-16-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1992.01080150103037","article-title":"Suppression of corneal neovascularization with cyclosporine.","volume":"110","author":"Lipman","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R6-16-20210204","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02713688508999984","article-title":"Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea.","volume":"4","author":"Mahoney","year":"1985","journal-title":"Curr Eye Res"},{"key":"R7-16-20210204","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/S0161-6420(86)33581-4","article-title":"Corneal argon laser photocoagulation for neovascularization in penetrating keratoplasty.","volume":"93","author":"Nirankari","year":"1986","journal-title":"Ophthalmology"},{"key":"R8-16-20210204","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00417-007-0542-4","article-title":". Inhibition of corneal angiogenesis by ascorbic acid in the rat model.","volume":"245","author":"Peyman","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-16-20210204","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels.","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-16-20210204","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00417-002-0591-7","article-title":". Inhibition of experimental angiogenesis of cornea by somatostatin.","volume":"241","author":"Wu","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-16-20210204","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/S0001-37652007000300004","article-title":"The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea.","volume":"79","author":"Barros","year":"2007","journal-title":"An Acad Bras Cienc"},{"key":"R12-16-20210204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","article-title":". Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.","volume":"27","author":"Hurmeric","year":"2008","journal-title":"Cornea"},{"key":"R13-16-20210204","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":". Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.","volume":"145","author":"Papathanassiou","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R14-16-20210204","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199105303242206","article-title":"Heparin.","volume":"324","author":"Hirsh","year":"1991","journal-title":"N Engl J Med"},{"key":"R15-16-20210204","doi-asserted-by":"crossref","first-page":"14683","DOI":"10.1073\/pnas.94.26.14683","article-title":". The anticoagulant activation of antithrombin by heparin.","volume":"94","author":"Jin","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-16-20210204","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0012-1606(03)00356-7","article-title":". Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling.","volume":"262","author":"Haigh","year":"2003","journal-title":"Dev Biol"},{"key":"R17-16-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02644769","article-title":"Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.","volume":"26","author":"Rusnati","year":"1996","journal-title":"Int J Clin Lab Res"},{"key":"R18-16-20210204","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1083\/jcb.107.2.743","article-title":". Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.","volume":"107","author":"Saksela","year":"1988","journal-title":"J Cell Biol"},{"key":"R19-16-20210204","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11095-006-9139-6","article-title":". Antiangiogenic effect of bile acid acylated heparin derivative.","volume":"24","author":"Park","year":"2007","journal-title":"Pharm Res"},{"key":"R20-16-20210204","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jconrel.2006.05.017","article-title":". Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity.","volume":"114","author":"Park","year":"2006","journal-title":"J Control Release"},{"key":"R21-16-20210204","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00109-002-0397-4","article-title":"The role of VEGF in normal and neoplastic hematopoiesis.","volume":"81","author":"Gerber","year":"2003","journal-title":"J Mol Med"},{"key":"R22-16-20210204","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/ijc.24239","article-title":". Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor.","volume":"124","author":"Lee","year":"2009","journal-title":"Int J Cancer"},{"key":"R23-16-20210204","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":". Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).","volume":"91","author":"Manzano","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R24-16-20210204","first-page":"473","article-title":". Quantitation of corneal neovascularization using computerized image analysis.","volume":"58","author":"Proia","year":"1988","journal-title":"Lab Invest"},{"key":"R25-16-20210204","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/ICO.0b013e31804f5a45","article-title":". Inhibitory effects of topical thymoquinone on corneal neovascularization.","volume":"26","author":"Erdurmus","year":"2007","journal-title":"Cornea"},{"key":"R26-16-20210204","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.ico.0000220768.11778.60","article-title":". Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.","volume":"25","author":"Riazi-Esfahani","year":"2006","journal-title":"Cornea"},{"key":"R27-16-20210204","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/ICO.0b013e31823f8b9c","article-title":". Inhibition of corneal neovascularization in rats by systemic administration of sorafenib.","volume":"31","author":"Seo","year":"2012","journal-title":"Cornea"},{"key":"R28-16-20210204","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors.","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"R29-16-20210204","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","article-title":"Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.","volume":"26","author":"Avery","year":"2006","journal-title":"Retina"},{"key":"R30-16-20210204","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion.","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R31-16-20210204","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R32-16-20210204","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","article-title":"Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"R33-16-20210204","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000144030","article-title":". Clinical and experimental research of corneal lymphangiogenesis after keratoplasty.","volume":"222","author":"Ling","year":"2008","journal-title":"Ophthalmologica"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e3182a48009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:36:25Z","timestamp":1621884985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201311000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3182a48009","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}